Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

Blood Adv (2021) 5 (16): 3203–3215.

https://doi.org/10.1182/bloodadvances.2021004976

Published: 2021

Includes: Supplemental data

Journal Articles

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens, Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, Elke De Bruyne

Blood Adv (2021) 5 (9): 2325–2338.

https://doi.org/10.1182/bloodadvances.2020003217

Published: 2021

Includes: Supplemental data

Journal Articles

JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells

Blood Adv (2021) 5 (3): 889–899.

https://doi.org/10.1182/bloodadvances.2020002702

Published: 2021

Includes: Supplemental data

Journal Articles

Hurdles in treating Hurler disease: potential routes to achieve a “real” cure

Brigitte T. A. van den Broek, Jaap van Doorn, Charlotte V. Hegeman, Stefan Nierkens, Caroline A. Lindemans, Nanda Verhoeven-Duif, Jaap Jan Boelens, Peter M. van Hasselt

Blood Adv (2020) 4 (12): 2837–2849.

https://doi.org/10.1182/bloodadvances.2020001708

Published: 2020

Journal Articles

IκB kinase 2 is not essential for platelet activation

Manuel Salzmann, Sonja Bleichert, Bernhard Moser, Marion Mussbacher, Mildred Haase, Bastian Hoesel, Waltraud C. Schrottmaier, Julia B. Kral-Pointner, Makoto Itakura, Katy Schmidt, Alice Assinger, Johannes A. Schmid

Blood Adv (2020) 4 (4): 638–643.

https://doi.org/10.1182/bloodadvances.2019001044

Published: 2020

Includes: Supplemental data

Journal Articles

Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes

Frederic Picou, Christine Vignon, Christelle Debeissat, Sébastien Lachot, Olivier Kosmider, Nathalie Gallay, Amelie Foucault, Marie-Hélène Estienne, Noémie Ravalet, Marie C. Bene, Jorge Domenech, Emmanuel Gyan, Michaela Fontenay, Olivier Herault

Blood Adv (2019) 3 (24): 4271–4279.

https://doi.org/10.1182/bloodadvances.2019000677

Published: 2019

Includes: Supplemental data

Journal Articles

Decoding the role of SOD2 in sickle cell disease

Atinuke M. Dosunmu-Ogunbi, Katherine C. Wood, Enrico M. Novelli, Adam C. Straub

Blood Adv (2019) 3 (17): 2679–2687.

https://doi.org/10.1182/bloodadvances.2019000527

Published: 2019

Journal Articles

Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma

Ajinkya Patil, Mark Manzano, Eva Gottwein

Blood Adv (2019) 3 (14): 2105–2117.

https://doi.org/10.1182/bloodadvances.2019031732

Published: 2019

Includes: Supplemental data

Journal Articles

Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development

Jose A. Hernandez, Victoria L. Castro, Nayeli Reyes-Nava, Laura P. Montes, Anita M. Quintana

Blood Adv (2019) 3 (8): 1244–1254.

https://doi.org/10.1182/bloodadvances.2018024539

Published: 2019

Includes: Supplemental data

Journal Articles

Role of CYP3A4 in bone marrow microenvironment–mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors

Yu-Ting Chang, Daniela Hernandez, Salvador Alonso, Minling Gao, Meng Su, Gabriel Ghiaur, Mark J. Levis, Richard J. Jones

Blood Adv (2019) 3 (6): 908–916.

https://doi.org/10.1182/bloodadvances.2018022921

Published: 2019

Includes: Supplemental data

Journal Articles

Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells

Scott Best, Taylor Hashiguchi, Adam Kittai, Nur Bruss, Cody Paiva, Craig Okada, Tingting Liu, Allison Berger, Alexey V. Danilov

Blood Adv (2019) 3 (1): 51–62.

https://doi.org/10.1182/bloodadvances.2018026880

Published: 2019

Includes: Supplemental data

Journal Articles

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

Hairui Su, Chiao-Wang Sun, Szu-Mam Liu, Xin He, Hao Hu, Kevin M. Pawlik, Tim M. Townes, Xiaosi Han, Christopher A. Klug, Maged Henary, Yabing Chen, Ling Li, Y. George Zheng, Xinyang Zhao

Blood Adv (2018) 2 (21): 2829–2836.

https://doi.org/10.1182/bloodadvances.2018020727

Published: 2018

Includes: Supplemental data

Journal Articles

Blood group ABO gene–encoded A transferase catalyzes the biosynthesis of FORS1 antigen of FORS system upon Met69Thr/Ser substitution

Emili Cid, Miyako Yamamoto, Fumiichiro Yamamoto

Blood Adv (2018) 2 (12): 1371–1381.

https://doi.org/10.1182/bloodadvances.2018017293

Published: 2018

Journal Articles

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion

Yi Luo, Lijian Shao, Jianhui Chang, Wei Feng, Y. Lucy Liu, Michele H. Cottler-Fox, Peter D. Emanuel, Martin Hauer-Jensen, Irwin D. Bernstein, Lingbo Liu, Xing Chen, Jianfeng Zhou, Peter J. Murray, Daohong Zhou

Blood Adv (2018) 2 (8): 859–870.

https://doi.org/10.1182/bloodadvances.2018015685

Published: 2018

Includes: Supplemental data

Journal Articles

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites

Katrin J. Czogalla, Kerstin Liphardt, Klara Höning, Veit Hornung, Arijit Biswas, Matthias Watzka, Johannes Oldenburg

Blood Adv (2018) 2 (6): 691–702.

https://doi.org/10.1182/bloodadvances.2017006775

Published: 2018

Includes: Supplemental data

Journal Articles

Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors

Alexey Dementiev, Abel Silva, Calvin Yee, Zhe Li, Michael T. Flavin, Hing Sham, James R. Partridge

Blood Adv (2018) 2 (5): 549–558.

https://doi.org/10.1182/bloodadvances.2018016337

Published: 2018

Includes: Supplemental data

Journal Articles

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

Peter G. Maslak, Tao Dao, Yvette Bernal, Suzanne M. Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit Rampal, Jae H. Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S. Tallman, David A. Scheinberg

Blood Adv (2018) 2 (3): 224–234.

https://doi.org/10.1182/bloodadvances.2017014175

Published: 2018

Includes: Supplemental data

Journal Articles

ABO blood group A transferases catalyze the biosynthesis of FORS blood group FORS1 antigen upon deletion of exon 3 or 4

Miyako Yamamoto, Emili Cid, Fumiichiro Yamamoto

Blood Adv (2017) 1 (27): 2756–2766.

https://doi.org/10.1182/bloodadvances.2017009795

Published: 2017

Includes: Supplemental data

Journal Articles

Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation

Mieke Aldenhoven, Brigitte T. A. van den Broek, Robert F. Wynn, Anne O’Meara, Paul Veys, Attilio Rovelli, Simon A. Jones, Rossella Parini, Peter M. van Hasselt, Marleen Renard, Victoria Bordon, Tom J. de Koning, Jaap Jan Boelens

Blood Adv (2017) 1 (24): 2236–2242.

https://doi.org/10.1182/bloodadvances.2017011387

Published: 2017

Includes: Supplemental data

Journal Articles

CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naïve and memory cells

Sylvain Meunier, Catherine Menier, Elodie Marcon, Sébastien Lacroix-Desmazes, Bernard Maillère

Blood Adv (2017) 1 (21): 1842–1847.

https://doi.org/10.1182/bloodadvances.2017008706

Published: 2017

Includes: Supplemental data

NARROW

Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells

Hurdles in treating Hurler disease: potential routes to achieve a “real” cure

IκB kinase 2 is not essential for platelet activation

Bone marrow oxidative stress and specific antioxidant signatures in myelodysplastic syndromes

Decoding the role of SOD2 in sickle cell disease

Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma

Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development

Role of CYP3A4 in bone marrow microenvironment–mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors

Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

Blood group ABO gene–encoded A transferase catalyzes the biosynthesis of FORS1 antigen of FORS system upon Met69Thr/Ser substitution

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites

Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia

ABO blood group A transferases catalyze the biosynthesis of FORS blood group FORS1 antigen upon deletion of exon 3 or 4

Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation

CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naïve and memory cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only